{"id":"https://openalex.org/W2074785386","doi":"https://doi.org/10.4088/jcp.v67n0712","title":"Comparison of Quetiapine and Risperidone in the Treatment of Schizophrenia","display_name":"Comparison of Quetiapine and Risperidone in the Treatment of Schizophrenia","publication_year":2006,"publication_date":"2006-07-15","ids":{"openalex":"https://openalex.org/W2074785386","doi":"https://doi.org/10.4088/jcp.v67n0712","mag":"2074785386","pmid":"https://pubmed.ncbi.nlm.nih.gov/16889453"},"language":"en","primary_location":{"id":"doi:10.4088/jcp.v67n0712","doi":"https://doi.org/10.4088/jcp.v67n0712","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v67n0712","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112039203","display_name":"Kate Zhong","orcid":"https://orcid.org/0009-0002-1399-2232","observed_orcids":["https://orcid.org/0009-0002-1399-2232"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kate X. Zhong","raw_affiliation_strings":["AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109137113","display_name":"Dennis E. Sweitzer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Dennis E. Sweitzer","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031075094","display_name":"Robert M. Hamer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert M. Hamer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5075093461","display_name":"Jeffrey Alan Lieberman","orcid":"https://orcid.org/0000-0002-1899-1776","observed_orcids":["https://orcid.org/0000-0002-1899-1776"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey A. Lieberman","raw_affiliation_strings":["Columbia University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University","institution_ids":["https://openalex.org/I78577930"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.9379,"has_fulltext":false,"cited_by_count":65,"citation_normalized_percentile":{"value":0.96351894,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"67","issue":"07","first_page":"1093","last_page":"1103"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":0.8679999709129333},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":1.0},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9490000009536743},{"id":"https://openalex.org/keywords/antipsychotic-efficacy","display_name":"antipsychotic efficacy","score":0.8090000152587891},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7239999771118164},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.8140000104904175},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.8339999914169312},{"id":"https://openalex.org/keywords/sleepiness","display_name":"sleepiness","score":0.9769999980926514},{"id":"https://openalex.org/keywords/prolactin","display_name":"prolactin","score":0.9259999990463257},{"id":"https://openalex.org/keywords/cognitive-function","display_name":"cognitive function","score":0.5759999752044678},{"id":"https://openalex.org/keywords/social-functioning","display_name":"social functioning","score":0.8650000095367432},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.7609999775886536},{"id":"https://openalex.org/keywords/typical-antipsychotics","display_name":"typical antipsychotics","score":0.671999990940094}],"concepts":[{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.9428333044052124},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.880224883556366},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6055081486701965},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5625851154327393},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5038632750511169},{"id":"https://openalex.org/C2911140283","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine Fumarate","level":5,"score":0.44295814633369446},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.42033350467681885},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.419938325881958},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.3281174302101135},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.1823214292526245}],"mesh":[{"descriptor_ui":"D000069348","descriptor_name":"Quetiapine Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001480","descriptor_name":"Basal Ganglia Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006966","descriptor_name":"Hyperprolactinemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006970","descriptor_name":"Disorders of Excessive Somnolence","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.4088/jcp.v67n0712","doi":"https://doi.org/10.4088/jcp.v67n0712","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v67n0712","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:16889453","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16889453","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2081028045","https://openalex.org/W2383029148","https://openalex.org/W2365782482","https://openalex.org/W2386943302","https://openalex.org/W2368342373","https://openalex.org/W2349555307","https://openalex.org/W2048681075","https://openalex.org/W2091054476","https://openalex.org/W2386656324","https://openalex.org/W2141441326"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"compare":[2],"the":[3,12],"efficacy":[4,53],"and":[5,9,61,85,87,96,101,160,192,204,208,261,272,275,293],"tolerability":[6],"of":[7,14,212],"quetiapine":[8,33,45,121,225,235,253],"risperidone":[10,37,131,222,238,247,262],"in":[11,59,78,98,174,187,201],"treatment":[13,198],"schizophrenia.":[15],"METHOD:":[16],"In":[17],"this":[18],"8-week,":[19],"double-blind,":[20],"multicenter,":[21],"flexible-dose":[22],"study,":[23],"patients":[24,165],"with":[25,151,221,234,246,252,290,300],"schizophrenia":[26],"(DSM-IV":[27],"diagnosis)":[28],"were":[29,104,117,154,195,206,297],"randomly":[30,118],"assigned":[31,119],"to":[32,49,109,120],"(200-800":[34],"mg/day)":[35,129],"or":[36,74,130,284],"(2-8":[38],"mg/day).":[39,139],"The":[40,51,140,210],"primary":[41,52,141],"hypothesis":[42],"was":[43,46,55,218,231,287],"that":[44],"not":[47,183],"inferior":[48],"risperidone.":[50,301],"measure":[54],"change":[56],"from":[57,106],"baseline":[58],"Positive":[60],"Negative":[62],"Syndrome":[63],"Scale":[64],"(PANSS)":[65],"total":[66],"scores;":[67],"secondary":[68],"outcomes":[69],"included":[70,92],"response":[71,189],"rate":[72,211],"(>":[73],"=":[75,115,123,127,133,137,170,241],"40%":[76],"reduction":[77],"PANSS":[79,157,175,188],"scores),":[80],"Clinical":[81],"Global":[82],"Impression-Change":[83],"(CGI-C),":[84],"cognitive":[86,193,271],"social":[88,273],"functioning.":[89],"Tolerability":[90],"assessments":[91],"treatment-emergent":[93],"adverse":[94,216],"events":[95,217],"changes":[97],"weight,":[99],"glucose,":[100],"prolactin.":[102],"Patients":[103,113],"recruited":[105],"June":[107],"2001":[108],"September":[110],"2002.":[111],"RESULTS:":[112],"(N":[114,122,132],"673)":[116],"338,":[124],"mean":[125,135],"dose":[126,136],"525":[128],"335,":[134],"5.2":[138],"analysis":[142],"demonstrated":[143],"noninferiority":[144],"between":[145,197],"treatments":[146,153],"(p":[147,169],"<":[148,228,257],".05).":[149],"Improvements":[150,186],"both":[152],"comparable":[155,265],"on":[156,282],"total,":[158],"negative,":[159],"general":[161],"psychopathology":[162],"subscales.":[163],"Risperidone-treated":[164],"had":[166,263,277],"a":[167,278],"significantly":[168,219,298],".03)":[171],"greater":[172],"improvement":[173],"positive":[176],"subscale":[177],"score":[178],"among":[179,184],"all":[180],"patients,":[181],"but":[182,250],"completers.":[185],"rates,":[190],"CGI-C,":[191],"function":[194],"similar":[196],"groups.":[199],"Changes":[200],"serum":[202],"glucose":[203],"weight":[205,283],"minimal":[207],"comparable.":[209],"extrapyramidal":[213],"symptom":[214],"(EPS)-related":[215],"higher":[220,299],"(22%)":[223],"than":[224,237],"(13%;":[226],"p":[227,240,256],".01).":[229],"Somnolence":[230,286],"more":[232,288],"common":[233,289],"(26%)":[236],"(20%;":[239],".04).":[242],"Prolactin":[243],"levels":[244],"increased":[245],"(+35.5":[248],"ng/mL),":[249],"decreased":[251],"(-11.5":[254],"ng/mL;":[255],".001).":[258],"CONCLUSIONS:":[259],"Quetiapine":[260],"broadly":[264],"clinical":[266],"efficacy.":[267],"Both":[268],"agents":[269],"improved":[270],"functioning,":[274],"neither":[276],"clinically":[279],"significant":[280],"effect":[281],"glucose.":[285],"quetiapine;":[291],"EPS":[292],"elevated":[294],"prolactin":[295],"rates":[296]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}